CHEK2 1100delC mutation is frequent among Russian breast cancer patients
- PMID: 16758118
- DOI: 10.1007/s10549-006-9227-7
CHEK2 1100delC mutation is frequent among Russian breast cancer patients
Abstract
This study was aimed to assess the role of CHEK2 1100delC mutation in breast cancer (BC) predisposition in Russia. The 1100delC allele was detected in 14/660 (2.1%) unilateral BC cases and in 8/155 (5.2%) patients with the bilateral form of the disease, but only in 1/448 (0.2%) middle-aged control females and in none of 373 elderly tumor-free women. The obtained data point at potentially high clinical relevance of CHEK2 1100delC testing in females of Russian origin and warrant similar case-control studies in ethnically and geographically related regions, especially in Ukraine, Belarus and Baltic countries.
Comment in
-
Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?Breast Cancer Res Treat. 2007 Jul;103(3):371. doi: 10.1007/s10549-006-9374-x. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063273 No abstract available.
-
CHEK2 1100delC is present in familial breast cancer cases of the Basque Country.Breast Cancer Res Treat. 2007 May;103(1):111-3. doi: 10.1007/s10549-006-9351-4. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063278 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
